What analysts say about ProShares Trust ProShares Ultra Nasdaq Biotechnology stock - Over 200 percent growth - jammulinksnews.com
LBTD Stock | USD 0.01 0.00 0.00% |
About 56% of Lotus Bio's investor base is looking to short. The analysis of overall sentiment of trading Lotus Bio Technology Development pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Lotus Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Lotus Bio Technology stock news signals to limit their universe of possible portfolio assets.
Lotus Bio pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lotus daily returns and investor perception about the current price of Lotus Bio Technology Development as well as its diversification or hedging effects on your existing portfolios.
Lotus |
What analysts say about ProShares Trust ProShares Ultra Nasdaq Biotechnology stock - Over 200 percent growth jammulinksnews.com
Read at news.google.com
![]() |
Lotus Bio Fundamental Analysis
We analyze Lotus Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Lotus Bio is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Lotus Bio Technology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lotus Bio pink sheet to make a market-neutral strategy. Peer analysis of Lotus Bio could also be used in its relative valuation, which is a method of valuing Lotus Bio by comparing valuation metrics with similar companies.
Peers
Lotus Bio Related Equities
AVD | American Vanguard | 6.67 | ||||
ARLSF | Argo Living | 5.08 | ||||
IPI | Intrepid Potash | 0.57 | ||||
NTR | Nutrien | 0.14 | ||||
BIOX | Bioceres Crop | 0.28 | ||||
ICL | ICL Israel | 0.33 | ||||
LVRO | Lavoro Limited | 3.38 |
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio's price analysis, check to measure Lotus Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio is operating at the current time. Most of Lotus Bio's value examination focuses on studying past and present price action to predict the probability of Lotus Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio's price. Additionally, you may evaluate how the addition of Lotus Bio to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |